News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 4DX market cap is 269.71M. The company's latest EPS is AUD -0.0805 and P/E is -8.57.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 0 | 1.23M | 217k | 1.05M | 719k |
| Operating Income | 0 | -13.82M | -18.79M | -24.43M | -31.42M |
| Net Income | 0 | -21.98M | -21.42M | -24.59M | -31.46M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 65.06M | 15.83M | 92.64M | 74.31M | 92.92M |
| Total Liabilities | 3.43M | 27.63M | 9.28M | 14.8M | 21.46M |
| Total Equity | 61.62M | -11.81M | 83.36M | 59.51M | 71.46M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | N/A | -7.65M | -14.52M | -25.27M | -22.65M |
| Investing | N/A | -786k | -580k | -3.5M | -1.61M |
| Financing | N/A | 13.78M | 87.55M | -995k | 42.73M |
| Market Cap | 269.71M |
| Price to Earnings Ratio | -8.57 |
| Price to Sales Ratio | 383.33 |
| Price to Cash Ratio | 3.88 |
| Price to Book Ratio | 3.77 |
| Dividend Yield | - |
| Shares Outstanding | 390.88M |
| Average Volume (1 week) | 274.67k |
| Average Volume (1 Month) | 467.32k |
| 52 Week Change | -16.87% |
| 52 Week High | 1.10 |
| 52 Week Low | 0.455 |
| Spread (Intraday) | 0.01 (0.72%) |
| Company Name | 4DMedical Limited |
| Address |
suite 501 level 5, 468 st kilda road melbourne, victoria 3004 |
| Website | https://www.4dmedical.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
